Headline
The latest stories from AHA Today.
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the longstanding upfront discount model, the Health Resources and Services Administration should take “immediate enforcement action,” including…
Cybersecurity experts from the AHA and Microsoft discuss the urgent need to build a cyber-strong workforce, particularly in rural hospitals and health systems, and how methods such as re-skilling can sustain permanent cyber readiness.
AHA Aug. 23 has named James “Scott” Gee as deputy national advisor for cybersecurity and risk.
Johnson & Johnson announced Aug. 23 that it would be fundamentally changing the way it makes 340B pricing available for two of its most popular products, Stelara and Xarelto.
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests.
The Health Resources and Services Administration announced Aug. 20 $1.4 billion in program funding for individuals with HIV who have low incomes to receive medication, health care and support services.
Two clinicians and a vehicle — that's the model Sheppard Pratt has been using to give behavioral health access to its communities.
The Department of Health and Human Services Health Sector Cybersecurity Coordination Center (HC3) this week released an advisory about Everest, a ransomware-as-a-service group increasingly targeting the health care field.
A Texas federal court Aug. 20 ruled set aside the Federal Trade Commission’s Non-Compete Clause Final Rule. U.S. District Judge Ada Brown held the FTC lacked the authority to enact the rule, which would ban, as an unfair method of competition, contractual terms that prohibit workers from pursuing…
The Centers for Disease Control COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been since January 2022.